This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Learn about the efficacy and safety of Somavert, its tumour impact and its effect on co-morbidity management through clinical and real world data

The acromegaly disease activity tool designed to help monitor your patients

Advice and support services to help you and your patients optimise your experience with Somavert about the efficacy and safety of Somavert through clinical and real world data

Learn about funding and reimbursement England, Scotland, Wales and Northern Ireland

Watch and listen to acromegaly experts talk about various topics in the disease area as well as recordings from our National Nurse Meeting and the Acromegaly co-morbidity series

Click here for Somavert® (pegvisomant) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Somavert is used in the treatment of adult patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalise IGF-I concentrations or was not tolerated.

Somavert patient starter kits 

Starter kit contents are designed to help your patients feel confident with Somavert and self-administration

Each Somavert starter kit contains*:

Patient information booklets

  • About Acromegaly
  • About Somavert, including the full user guide

Reconstitution guides

  • Preparing Somavert poster
  • USB stick with video guide

Practising tools

  • 3x Somavert demo packs (contains placebo)
  • Injection pad (for practising technique)
  • Injection site guide

Day-to-day injecting and ongoing support

  • Injection template for leg and abdomen
  • Box of swabs
  • Cool bag and instructions for use
  • Sharps bin
  • Helpline card

*Items are subject to change.

Homecare services

We offer a range of services that help your patients at home with medication delivery and face-to-face support 

Learn more

Order more starter kits

Order now

The Somavert prescribing guide

Find information on funding, initiation, homecare and follow-up

Download the guide
PP-SOM-GBR-1012. September 2021

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No